By Endovascular Today
Published 10-04-22
Submitted by Boston Scientific
Originally Published by Endovascular Today on evtoday.com
Truveta announced a strategic collaborative agreement with Boston Scientific Corporation whereby Boston Scientific researchers will be able to access data from Truveta that contains deidentified medical records from more than 65 million patients in the United States.
According to Truveta, the collaboration seeks to improve long-term patient care and gain insights into health care disparities.
Continue reading here.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
More from Boston Scientific